BLOGS >

Voices

RSS
Engage with independent insights, opinions, and analysis from an array of leaders in cardiology.
Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: October 13th (13 Oct 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include a comparison of once-weekly dulaglutide and once-daily liraglutide in metformin-treated patients with type 2 diabetes and variation in patients’ perceptions of elective PCI in stable CAD.

Avatar of Behnood Bikdeli, M.D.

Heart Failure Readmissions: Neighborhood Factors Matter, Too (13 Oct 2014)

Behnood Bikdeli, M.D.

For two decades, investigators have been studying the association between neighborhood characteristics and cardiovascular disease. A landmark study from 2001 showed that living in a socioeconomically disadvantaged neighborhood was associated with higher incidence of coronary artery disease. Several studies have also shown an association between neighborhood characteristics, most notably the socioeconomic status (SES) and outcomes of patients with heart failure (HF). Previous studies, however, have not clarified whether neighborhood factors are merely a proxy for individual-level factors or are independent predictors of HF outcomes. My colleagues and I recently published… Continue Reading

Avatar of Larry Husten, PHD

Why Bad Doctors Are Like Bad Writers: The Curse Of Knowledge (9 Oct 2014)

Larry Husten, PhD

Larry Husten applies Steven Pinker’s ideas about the difficulties of writing to the field of medicine by looking at what makes it difficult for doctors to communicate with their patients.

Avatar of Harlan M. Krumholz, MD, SM

Another Reason for Open Access to Clinical Trial Data? (7 Oct 2014)

Harlan M. Krumholz, MD, SM

A correction to the RE-LY trial results, partly brought to light because of litigation, has Harlan Krumholz wondering if this is another example of why we should have open access to clinical trial data.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: October 6th (6 Oct 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include medical device safety and effectiveness, familial hypercholesterolemia, and more.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: September 29th (29 Sep 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include prevalence and incidence trends in diabetes in the U.S., quality of life outcomes with CABG in ischemic left ventricular dysfunction, and more.

Avatar of Clyde Yancy, MD

The Implications of PARADIGM-HF for Clinical Practice (29 Sep 2014)

Clyde Yancy, MD and Mary Norine Walsh, MD

Clyde Yancy and Mary Norine Walsh offer their perspectives on the much-discussed PARADIGM-HF trial.

Avatar of John

Pulmonary Arterial Hypertension Treatment Worldwide: A Lack of Standardized Care (25 Sep 2014)

John Ryan, MD

John Ryan discusses his new paper on heterogeneity in pulmonary arterial hypertension clinical practice worldwide. Are you surprised by the lack of standardized care?

Avatar of Westby G Fisher, MD

Another MacGyver Moment in Pacemaker Implantation (22 Sep 2014)

Westby G Fisher, MD

Dr. Westby Fisher gets creative with his medical technology.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: September 22nd (22 Sep 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include one-year outcomes after thrombus aspiration for MI, the evaluation and treatment of older patients with hypercholesterolemia, and more.